Janssen-Cilag G.m.b.H
23
5
7
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
17.4%
4 terminated/withdrawn out of 23 trials
69.2%
-17.3% vs industry average
30%
7 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Role: lead
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
Role: collaborator
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
Role: collaborator
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Role: collaborator
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
Role: collaborator
PsoBest - The German Psoriasis Registry
Role: collaborator
Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Role: collaborator
Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma
Role: collaborator
Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage
Role: collaborator
Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma
Role: collaborator
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
Role: collaborator
A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Role: lead
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Role: lead
Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients
Role: collaborator
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
Role: lead
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
Role: lead
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
Role: lead
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Role: collaborator
Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma
Role: lead
Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
Role: lead